Showing results (671-680 of 911) with videos related to

Sort By:
Pageof 92
The Lancet. Psychiatry|December 2, 2015
Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness: a systematic review and meta-analysisElizabeth Hughes, Shaan Bassi, Simon Gilbody, et al.
The Lancet. Psychiatry|March 8, 2016
Brain-imaging studies of treatment-resistant schizophrenia: a systematic reviewElias Mouchlianitis, Robert McCutcheon, Oliver D Howes
The Lancet. Psychiatry|March 8, 2016
Trajectories of suicidal ideation in patients with first-episode psychosis: secondary analysis of data from the OPUS trialTrine Madsen, Karen-Inge Karstoft, Rikke Gry Secher, et al.
The Lancet. Psychiatry|December 20, 2015
Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) projectCraig W Ritchie, José Luis Molinuevo, Luc Truyen, et al.
The Lancet. Psychiatry|December 22, 2015
Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trialJohn R Geddes, Alexandra Gardiner, Jennifer Rendell, et al.
The Lancet. Psychiatry|February 7, 2016
Estimating the true global burden of mental illnessDaniel Vigo, Graham Thornicroft, Rifat Atun
The Lancet. Psychiatry|March 21, 2016
Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal studyCarrie Shilyansky, Leanne M Williams, Anett Gyurak, et al.
The Lancet. Psychiatry|January 19, 2025
Underlying mechanisms and efficacy of a suicide-focused psychological intervention for psychosis, the Cognitive Approaches to Combatting Suicidality (CARMS): a multicentre, assessor-masked, randomised controlled trial in the UKPatricia Gooding, Daniel Pratt, Danielle Edwards, et al.
The Lancet. Psychiatry|January 9, 2025
Evaluating ADHD medication trial representativeness: a Swedish population-based study comparing hypothetically trial-eligible and trial-ineligible individualsMiguel Garcia-Argibay, Zheng Chang, Isabell Brikell, et al.
The Lancet. Psychiatry|November 15, 2024
Prevalence, correlates, tolerability-related outcomes, and efficacy-related outcomes of antipsychotic polypharmacy: a systematic review and meta-analysisMikkel Højlund, Ole Köhler-Forsberg, Anton T Gregersen, et al.
Pageof 92